BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5062817)

  • 21. Inhibition of ribonucleotide reductase from Ehrlich tumor cells by RNA.
    Cory JG
    Cancer Res; 1973 May; 33(5):993-8. PubMed ID: 4735728
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetic studies on the inhibition of nucleoside diphosphate kinase by desdanine.
    Saeki T; Hori M; Umezawa H
    J Biochem; 1974 Sep; 76(3):623-9. PubMed ID: 4373447
    [No Abstract]   [Full Text] [Related]  

  • 23. FLUORINATED PYRIMIDINES. XXV. THE INHIBITION OF THYMIDYLATE SYNTHETASE FROM EHRLICH ASCITES CARCINOMA CELLS BY PYRIMIDINE ANALOGS.
    REYES P; HEIDELBERGER C
    Biochim Biophys Acta; 1965 May; 103():177-9. PubMed ID: 14336436
    [No Abstract]   [Full Text] [Related]  

  • 24. The specificity of chromium nucleotides as inhibitors of selected kinases.
    Janson CA; Cleland WW
    J Biol Chem; 1974 Apr; 249(8):2572-4. PubMed ID: 4362688
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the phosphoryl-enzyme intermediate concept in the acetate kinase and hexokinase reactions from kinetic studies.
    Purich DL; Fromm HJ
    Arch Biochem Biophys; 1972 Mar; 149(1):307-15. PubMed ID: 4552801
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of tubercidin and its ribonucleotides on various metabolic pathways in Schistosoma mansoni.
    Ross AF; Jaffe JJ
    Biochem Pharmacol; 1972 Nov; 21(22):3059-69. PubMed ID: 4346386
    [No Abstract]   [Full Text] [Related]  

  • 27. [The reverse phosphofructokinase reaction in ascites tumor cells (author's transl)].
    Sauermann G
    Hoppe Seylers Z Physiol Chem; 1974 Apr; 355(4):459-65. PubMed ID: 4279884
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved methods for the study of drug effects on purine metabolism and their application to nebularine and 7-deazanebularine.
    Smith CM; Snyder FF; Fontenelle LJ; Henderson JF
    Biochem Pharmacol; 1974 Jul; 23(14):2023-35. PubMed ID: 4371446
    [No Abstract]   [Full Text] [Related]  

  • 29. Kinetic properties of the arginine kinase isoenzymes of Limulus polyphemus.
    Blethen SL
    Arch Biochem Biophys; 1972 Mar; 149(1):244-51. PubMed ID: 5017253
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of deoxythymidine kinase activity by the virostatic 5-ethyl-2'-deoxyuridine.
    Gauri KK; Walter RD
    Chemotherapy; 1973; 18(5):269-73. PubMed ID: 4580524
    [No Abstract]   [Full Text] [Related]  

  • 31. On the reversibility of the first segment of glycolysis in ascites tumor cells.
    Sauermann G
    Biochim Biophys Acta; 1968 Apr; 158(1):1-10. PubMed ID: 4297373
    [No Abstract]   [Full Text] [Related]  

  • 32. The partial purification and properties of uridine kinase from Ehrlich ascites tumor cells.
    Krystal G; Scholefield PG
    Can J Biochem; 1973 Apr; 51(4):379-89. PubMed ID: 4696063
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation and mechanism of phosphoribosylpyrophosphate synthetase. V. Inhibition by end products and regulation by adenosine diphosphate.
    Switzer RL; Sogin DC
    J Biol Chem; 1973 Feb; 248(3):1063-73. PubMed ID: 4346344
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetic studies of the interaction of pigeon-liver NAD kinase with adenine nucleotides and divalent cations.
    Apps DK; Marsh A
    Eur J Biochem; 1972 Jun; 28(1):12-9. PubMed ID: 4340475
    [No Abstract]   [Full Text] [Related]  

  • 35. Transformation of glucosamine to glycogen and lactate by ascites tumor cells.
    Sukeno T; Kikuchi H; Saeki H; Tsuiki S
    Biochim Biophys Acta; 1971 Jul; 244(1):19-29. PubMed ID: 4330425
    [No Abstract]   [Full Text] [Related]  

  • 36. Computer simulation study of hexokinase II from Ehrlich ascites cells.
    Garfinkel L
    Eur J Biochem; 1975 Feb; 51(2):437-47. PubMed ID: 1149737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of the cellular content of ribonucleoside triphosphates induces cell shrinkage and KCl loss in Ehrlich ascites tumor cells and in Chinese hamster ovary cells.
    Marcussen M; Overgaard-Hansen K; Klenow H
    Biochim Biophys Acta; 1997 Oct; 1358(3):240-8. PubMed ID: 9366255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uridine kinase from Ehrlich ascites carcinoma. Purification and properties of homogeneous enzyme.
    Payne RC; Cheng N; Traut TW
    J Biol Chem; 1985 Aug; 260(18):10242-7. PubMed ID: 2991280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Product inhibition of the hexokinases.
    Kosow DP; Rose IA
    J Biol Chem; 1970 Jan; 245(1):198-204. PubMed ID: 5460798
    [No Abstract]   [Full Text] [Related]  

  • 40. Interconvertible forms of class A pyruvate kinase from Ehrlich ascites tumour cells.
    Felíu JE; Díaz-Gil J; García-Cañero R; Gosálvez M
    FEBS Lett; 1975 Feb; 50(3):334-8. PubMed ID: 1116604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.